Legacy Capital Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16,192
Closed -$1.61M 161
2019
Q3
$1.61M Sell
16,192
-12,460
-43% -$1.18M 0.7% 48
2019
Q2
$2.65M Sell
28,652
-790
-3% -$75K 1.18% 28
2019
Q1
$2.78M Buy
29,442
+1,580
+6% +$138K 1.3% 28
2018
Q4
$1.79M Sell
27,862
-84
-0.3% -$6.2K 0.95% 41
2018
Q3
$2.5M Buy
27,946
+500
+2% +$44.2K 1.15% 34
2018
Q2
$2.18M Sell
27,446
-300
-1% -$24.9K 1.07% 36
2018
Q1
$2.48M Sell
27,746
-3,615
-12% -$347K 1.24% 32
2017
Q4
$3.27M Sell
31,361
-245
-0.8% -$27.6K 1.62% 23
2017
Q3
$4.61M Buy
31,606
+2,086
+7% +$284K 2.42% 8
2017
Q2
$3.83M Sell
29,520
-289
-1% -$35.4K 2.07% 14
2017
Q1
$3.71M Buy
29,809
+1,885
+7% +$226K 2.08% 13
2016
Q4
$3.23M Buy
27,924
+259
+0.9% +$28.8K 1.96% 15
2016
Q3
$2.89M Hold
27,665
1.82% 18
2016
Q2
$2.73M Buy
27,665
+310
+1% +$32.1K 1.7% 19
2016
Q1
$2.74M Sell
27,355
-1,315
-5% -$135K 1.77% 17
2015
Q4
$3.43M Sell
28,670
-1,500
-5% -$174K 2.21% 12
2015
Q3
$3.26M Buy
30,170
+1,550
+5% +$192K 2.21% 12
2015
Q2
$3.31M Sell
28,620
-1,680
-6% -$192K 2.16% 12
2015
Q1
$3.49M Sell
30,300
-1,605
-5% -$192K 2.23% 10
2014
Q4
$3.57M Sell
31,905
-521
-2% -$54.9K 2.28% 10
2014
Q3
$3.07M Sell
32,426
-2,826
-8% -$255K 2.04% 13
2014
Q2
$3.03M Buy
35,252
+10,134
+40% +$771K 1.96% 15
2014
Q1
$1.75M Sell
25,118
-1,350
-5% -$107K 1.24% 27
2013
Q4
$2.24M Sell
26,468
-2,900
-10% -$229K 1.59% 21
2013
Q3
$2.26M Sell
29,368
-2,290
-7% -$160K 1.69% 17
2013
Q2
$1.85M Buy
+31,658
New +$1.91M 1.41% 21

Other funds holding CELG

Legacy Capital Partners's CELG Position: Q4 2019 in Review

Legacy Capital Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,192 shares — an estimated $1.61M sold.

Legacy Capital Partners first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.61M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Legacy Capital Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Legacy Capital Partners sold 16,192 Celgene Corp shares in Q4 2019, an estimated $1.61M.
  • Legacy Capital Partners first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Legacy Capital Partners's Celgene Corp position peaked at $4.61M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Legacy Capital Partners's 13F filing for Q4 2019, filed 14 Jan 2020.